Pfizer Inc at RBC Global Healthcare Conference (Virtual) Transcript
Great. Thanks, everybody, for joining us for our next virtual fireside chat here. We're kicking things off again with our next company. I'm Randall Stanicky, the pharmaceuticals analyst here at RBC Capital Markets.
And next up, we have Pfizer. The stock has proven resilient in the current pandemic. It's one of the names that we've been highlighting as defensive and wanting to own in this environment. And so with us to chat on the company, current dynamics and outlook here, Senior Vice President of Investor Relations, Chuck Triano.
And so Chuck, first, I just want to say thanks for joining us. It's great to have Pfizer at our conference. So thank you for that.
Questions & Answers
And then to start off, let's jump into DMD and the market opportunity. This was something that you guys sounded pretty excited about on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |